LexBlog IP

NOVEMBER 3, 2023

Instead, the TTAB focused primarily on the evidence submitted by RLP, specifically, that much of it was erroneously submitted under seal or improperly authenticated by Notice of Reliance. RLP submitted almost 1000 pages of trial exhibits completely under seal and did not provide the relevant public and redacted versions required by the Board.

Confidentiality 52

Confidentiality Registration Trademark Intellectual Property 52

Trading Secrets

JUNE 3, 2022

This blog post summarizes some of the significant decisions grouped by the hot topics below. Sufficiency of Trade Secret Pleadings and Allegations of Misappropriation. In Oakwood Lab’ys LLC v. Thanoo , 999 F.3d 3d 892 (3d Cir. The district court dismissed plaintiff’s complaint for failure to state a claim.

Law 59

Law Confidentiality Designs Design 59

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Biosimilar Approvals and Launches in 2021. Biosimilar Regulatory Updates. Legislation and Executive Orders Relating to Biologics and Biosimilars. BPCIA Litigation. Antitrust and Competition. Post-Grant Challenges at the PTAB. Conclusion. Biosimilar Approvals and Launches in 2021. Amgen’s Riabni ™ (rituximab-arrx) launched in January 2021.

Litigation 52

Litigation Settlement Patent Marketing 52

Technology & Marketing Law Blog

JANUARY 28, 2022

It contained a non-compete clause that said Gutman wouldn’t compete directly or indirectly with JLM during her employment. The agreement also granted a license to JLM in Gutman’s name (“Hayley, Paige, Hayley Paige Gutman, Hayley Gutman, Hayley Page, or any derivative thereof”). She also granted JLM rights in the trademarks relating to her name.

Social Media 89

Social Media Ownership Contracts Privacy 89